Patient Detail: Registration Location: Reference: Patient Number:

Sabir Hussain 905116 . Shaheed-e-Millat Road, Karachi Service Long March Tyres Employees (Annual Screening-KHI-Credit)
24401-25-15627402
Age/Sex Mobile # Registration Date: Consultant: Case Number:
45 Y(s) / M - 00000000000 16-Jan-2025 11:07 ....... 24409-16-01
Note : ,,,
Collection DateTime 16-Jan-2025 11:07
Department of Virology Reporting DateTime: 17-Jan-2025 02:24

Serum HBsAg

Reactive
Cutoff
Value 1.0
Patient
Value 207.71
Non Reactive <1.0 | Reactive ≥ 1.0

Electronically verified report. No signature required. Lab reports should be interpreted by a physician in correlation with clinical and radiologic findings.
Interpretation:
• Hepatitis B surface antigen (HBsAg) test is one of the triple panel screening tests, which also includes antibody to hepatitis B
surface antigen (anti-HBs), and total antibody to hepatitis B core antigen (total anti-HBc).
• HBsAg usually becomes undetectable after four to six months in acute infection, whereas persistence of HBsAg for more than six
months indicates chronic infection.
• A reactive result indicates an ongoing HBV infection, acute or chronic.
• A non-reactive result does not rule out the possibility of HBV exposure or infection as it may be seen in severely immuno-
compromised patients, patients on dialysis, or HBsAg mutants.
• False positive results may be due to heterophilic antibodies in human serum and after a dose of HBV vaccine.
Methodology: HBsAg test is performed on fully automated Chemiluminescence Microparticles Immunoassay Analyzer (CMIA),
Abbott Alinity i.
Reference: Centers for Disease Control and Prevention - Screening and Testing Recommendations for Chronic Hepatitis B Virus
Infection (HBV)
Note: Two lab intercomparison cannot be done due to difference in sample collection, transportation, storage, sensitivity, and
specificity of assay.

Serum Anti-HCV

Non-Reactive
Cutoff
Value 1.00
Patient
Value 0.08
Non Reactive < 1.0 | Reactive ≥ 1.0

Interpretation:
• Anti-HCV is a screening test for Hepatitis C which detects antibodies to Hepatitis C virus (HCV) infection.
• A reactive result indicates that the patient has evidence of acquisition of the HCV infection, particular chronic HCV infection, and
it should be followed by HCV RNA testing.
• A non-reactive result does not rule out the possibility of HCV exposure or infection as it may be seen in severely immuno-
compromised patients, patients on dialysis, or acute HCV infection.
• False positive results, though less frequent, may be due to passively acquired anti-HCV antibodies from blood transfusions,
heterophile antibodies, or cross-reactivity with other viral infections.
Methodology: Anti-HCV test is performed on fully automated Chemiluminescence Microparticles Immunoassay Analyzer (CMIA),
Abbott Alinity i.
Reference: Centers for Disease Control and Prevention - CDC Recommendations for Hepatitis C Screening Among Adults
Note: Two lab intercomparison cannot be done due to difference in sample collection, transportation, storage, sensitivity, and
specificity of assay.

Dr. N. A. Malik Dr. Ayisha Imran Dr. M. Dilawar Khan Dr. Omar Chughtai Dr. A . S. Chughtai
M.B.B.S. (Pb) , M. Phil. M.B.B.S., F.C.P.S. M.B.B.S., M.C.P.S., F.C.P.S. M.B.B.S., M.D., F.C.A.P. M.B.B.S., M.I.A.C., M.Phil.
Consultant Haematologist Consultant Haematologist Consultant Chemical Pathologist Diplomate American Board of Anatomic F.C.P.S., F.C.P.P.Consultant Pathologist
and Clinical Pathology Consultant
Pathologist
03111456789 [email protected] Shaheed-e-Millat Road Karachi www.chughtailab.com